These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39101441)

  • 1. A pilot study of safety and efficacy comparison of low molecular heparin calcium sequential oral anticoagulants in the treatment of cirrhotic portal vein thrombosis.
    Zhang J; Dang X; Zhang L; Li W
    Eur J Gastroenterol Hepatol; 2024 Sep; 36(9):1119-1125. PubMed ID: 39101441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
    Hanafy AS; Abd-Elsalam S; Dawoud MM
    Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban.
    Yang H; Kim SR; Song MJ
    Clin Mol Hepatol; 2016 Dec; 22(4):499-502. PubMed ID: 27880998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial.
    Zhou T; Sun X; Zhou T; Li Y; Chen X; Cheng B; Gao Y
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00228. PubMed ID: 32858573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
    J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and Safety of Early Versus Routine Switching from Low-Molecular-Weight Heparin to Maintenance Therapy of Rivaroxaban for Acute Iliofemoral Vein Thrombosis: A Retrospective Cohort Study.
    Hou W; Fang D; Yin S; Deng Y; Zhang J; Wang S; Liu L; Kong J; Huang M; Zhang X; Dai B; Feng X
    Ann Vasc Surg; 2024 Sep; 106():152-161. PubMed ID: 38815910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
    Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
    Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
    BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
    Signorelli JR; Gandhi AS
    J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
    Gao Z; Li S; Zhao J; Li J; Gao Y
    Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
    Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
    Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center.
    Hays K; Jolly M; Silver M; Phillips J; Huff C; Secic M; Ansel G; Kolluri R
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):753-759.e1. PubMed ID: 32827732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
    Tadokoro T; Tani J; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Fujita K; Nomura T; Morishita A; Kobara H; Himoto T; Ono M; Masaki T
    Sci Rep; 2024 May; 14(1):10784. PubMed ID: 38734732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.
    Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Germain G; Bookhart B; Pollack CV
    J Med Econ; 2016; 19(1):84-90. PubMed ID: 26390315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.